Author response for "Clinical significance of pre‐diabetes, undiagnosed diabetes, and diagnosed diabetes on clinical outcomes in COVID‐19: Integrative analysis from the Japan COVID‐19 Task Force"

Takahiro Fukushima, Kosaku Nanki(Keio University), Hirofumi Kamata(Keio University), Hitoshi Sasano(Keio University), Haruhi Takagi(Juntendo University), Shuhei Azekawa(Keio University), Naoki Hasegawa(Keio University), Takanori Kanai∥(Keio University), Yukinori Okada(RIKEN Center for Integrative Medical Sciences), Makoto Ishii(Tokyo Medical and Dental University), Shinnosuke Ikemura(Keio University), Seishi Ogawa(Keio University), Makoto Hiki(Juntendo University), Ryuji Koike(Tokyo Medical and Dental University), Katsunori Masaki(Keio University), Mayuko Watase(Keio University), Sonoko Harada(Juntendo University), Hideki Terai(Kitasato Institute Hospital), Atsuho Morita(Keio University), Hiroki Kabata(Keio University), Yoshifumi Uwamino(Keio University), Takuya Kusumoto, Takanori Asakura(Keio University), Norihiro Harada(Juntendo University), Toshio Naito(Juntendo University), Ho Namkoong(Keio University), Koichi Fukunaga(Keio University), Hiromu Tanaka(Keio University), Kensuke Nakagawara(Keio University), Kazuhisa Takahashi(Kansai Medical University), Hiroshi Morisaki(Keio University), Satoshi Okamori(Keio University), Shotaro Chubachi(Keio University), Satoru Miyano(Cardiovascular Institute Hospital), Junichi Sasaki(Institute for Atherosclerosis Research), Seiya Imoto(Tokyo Medical University), Ho Lee(National Cancer Center), Ai Nakamura, Yasushi Matsushita(Juntendo University), Kaori Sakurai(Tokyo University of Agriculture and Technology), Shiro Otake(Keio University), Akinori Kimura(The University of Tokyo)
Unknown
August 22, 2022
Cited by 0


Related Papers